Product Name :
BCAT1 Peptide Applications :
Blocking Background :
ECA39, also known as BCAT1 (branched-chain-amino-acid aminotransferase 1, cytosolic) is localized to the cytoplasm where it forms a homodimer. ECA39 is expressed in the brain and kidney during embryogenesis and is overexpressed in c-Myc induced tumors. BCAT2 (branched-chain-amino-acid aminotransferase 2, mitochondrial), also known as placental protein 18 (PP18), is expressed as two isoforms produced by alternative splicing. The first isoform of BCAT2, designated BCAT2A, is expressed in the mitochondrion, while the second isoform, designated BCAT2B, is expressed in the cytoplasm. Ubiquitously expressed, BCAT2 is also thought to act as a transporter of branched chain alpha-keto acids. Alternative Name :
Branched-chain-amino-acid aminotransferase, cytosolic; BCAT(c); Protein ECA39; BCT1; ECA39 Swiss-Prot :
P54687 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide BCAT1. (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS60374 BCAT1 pAb.

• 

Blocking peptide available as BS60374PP